Stryker (SYK) EBT Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.29% |
| Dec 31, 2025 | 20.50% |
| Sep 30, 2025 | 5.70% |
| Jun 30, 2025 | 68.74% |
| Mar 31, 2025 | 5.30% |
| Dec 31, 2024 | -10.82% |
| Sep 30, 2024 | 12.41% |
| Jun 30, 2024 | 12.05% |
| Mar 31, 2024 | 13.97% |
| Dec 31, 2023 | 13.29% |
| Sep 30, 2023 | 10.23% |
| Jun 30, 2023 | 7.61% |
| Mar 31, 2023 | 4.61% |
| Dec 31, 2022 | 3.24% |
| Sep 30, 2022 | 11.62% |
| Jun 30, 2022 | 10.15% |
| Mar 31, 2022 | -5.01% |
| Dec 31, 2021 | 5.18% |
| Sep 30, 2021 | 3.39% |
| Jun 30, 2021 | 8.86% |
| Mar 31, 2021 | -5.27% |
| Dec 31, 2020 | 1.86% |
| Sep 30, 2020 | 17.72% |
| Jun 30, 2020 | -17.26% |
| Mar 31, 2020 | 9.37% |
| Dec 31, 2019 | 15.22% |
| Sep 30, 2019 | 6.45% |
| Jun 30, 2019 | 27.60% |
| Mar 31, 2019 | 35.01% |
| Dec 31, 2018 | 8.80% |
| Sep 30, 2018 | 31.27% |
| Jun 30, 2018 | 18.29% |
| Mar 31, 2018 | 7.64% |
| Dec 31, 2017 | 12.63% |
| Sep 30, 2017 | 1.19% |
| Jun 30, 2017 | 0.41% |
| Mar 31, 2017 | 1.29% |
| Dec 31, 2016 | 6.31% |
| Sep 30, 2016 | -0.56% |
| Jun 30, 2016 | 1.10% |
| Mar 31, 2016 | 3.15% |
| Dec 31, 2015 | 10.06% |
| Sep 30, 2015 | -5.67% |
| Jun 30, 2015 | -1.93% |
| Mar 31, 2015 | -3.31% |
| Dec 31, 2014 | -2.50% |
| Sep 30, 2014 | 6.21% |
| Jun 30, 2014 | -16.03% |
| Mar 31, 2014 | -22.65% |